CTY · City Therapeutics, Inc. · Documents
Market Cap
$1.08B
Shares
50.33M
Volume · Oct 19
302.4K
Avg daily vol (2 sessions)
854.41K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | City Therapeutics filed an amended and restated certificate of incorporation in Delaware on October 19, 2026, authorizing 500,000,000 common shares and 10,000,000 undesignated preferred shares and eliminating stockholder written consent; its amended bylaws became effective October 15, 2026. | 2026-10-19 | 2026-10-15 | |
| S-1/A | — | 2026-10-09 | — | |
| S-1 | — | 2026-09-24 | — |
Showing 1–3 of 3 filings